Please login to the form below
recalls
This page shows the latest recalls news and features for those working in and with pharma, biotech and healthcare.
The mother of all nudges
You may recall that a few months ago (in PME, October 2019) I wrote a column about externalities and their importance in the context of public health.
Latest news
-
Trump administration advances drug importation plan
The proposal could prove difficult for other reasons, as it also requires importers to have knowledge of regulatory processes – including safety tests and being able to manage product recalls.
-
Brexit nears as Conservatives sweep to victory in election
Recall just before the 2016 vote he publicly backed staying in the single market, which would solve the Irish border problem at a stroke.
-
J&J to FDA: there really is no asbestos in Baby Powder
Tests were also done on three lots manufactured before and after the recall, but were also negative, says J&J. ... The recall of the lot (#22318RB) will however stay in effect as it is ‘not feasible’ to halt it, according to J&J.
-
The Unhappiness Project
I cannot recall a single chronic patient that I have ever met who has raved about the health system and how efficiently it operates.
-
GSK and Apotex join generic Zantac recalls as carcinogen concerns mount
Now GlaxoSmithKline, the original branded manufacturer of Zantac, has stopped global distribution of the medicine, and will recall the drug in India and Hong Kong. ... The FDA and other global health regulators are continuing to test different ranitidine
More from news
Approximately 10 fully matching, plus 189 partially matching documents found.
Latest Intelligence
-
Health trust in a COVID-19 world – a unique opportunity for pharma
This, you may recall, is the group which makes up 17% of the total global population.
-
COVID-19 hits supply chains
Eban’s best-selling exposé, Bottle of Lies, describes how substandard manufacturing conditions traced to Chinese facilities led to drug recalls and patient deaths. ... The valsartan recall was particularly dismaying because a year prior to that, an
-
A roadmap to the successful treatment of Alzheimer’s disease
Living to tell the tale. Having worked in cancer research 20 years ago, I recall there was often a feeling across the field that we had hit a brick wall and
-
Right intervention, right tool
Can this intervention impart knowledge as well as it can explore recall?
-
Cutting through the noise
Decisions, such as referring colleagues, are often based on emotion; a positive emotional experience will also help with recall, increasing educational value.
More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.
Latest appointments
-
J&J appoints Bayer’s Sandra Peterson as group worldwide chair
by recalls and quality control problems these past two years.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Changing healthcare, one film at a time
Emotionally resonant content is also linked with improved attention and recall, two crucial aspects of any effective healthcare communications campaign.
-
WHITE PAPER: Marketing fulfilment – a balancing act
4. Are you ready for anything? How ready are you for a recall? ... As with any element of crisis management, it’s worth establishing a process for handling marketing collateral in case of a recall.
-
Experiential Marketing
At the beginning of this post, I asked you to recall a favourite day.
-
Secrets of Pharma Advertising
Ask someone to unpick an ad for a new dermatology product, and they will compare it to other dermatology ads they recall, expressing confusion at anything that looks different.
-
Health Literacy in Practice: Doctor's Letter
Using more colour. Colour can increase a reader’s attention span and recall by 82%[2] and is a great way of drawing attention to the most important information for the
More from PMHub
Approximately 0 fully matching, plus 16 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- AZ strengthens Daiichi Sankyo partnership with new ADC deal
- New study identifies drugs that are safe to use in COVID-19 treatment
- AbbVie, Amgen and Takeda team up for joint COVID-19 trial
- How will the events and exhibitions industry change post-Coronavirus?
- AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapies
- Eli Lilly begins COVID-19 prevention trial in nursing homes
- Porterhouse Medical Group joins imc group
- Biogen pays Denali $1bn upfront for Parkinson’s disease programme
- Tecentriq combo fails in advanced triple negative breast cancer
- Bristol-Myers Squibb’s revenues rise on Celgene acquisition
- Socially distanced strategising
- Artificial Intelligence in Digital Therapeutics
PMHub
JPA Health
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...
Latest intelligence
- Virtual Engagement At Porterhouse: Reflections on the past few months
- A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
- July 2020: diversity and inclusion in clinical trials round-up
- COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
- Medical Device Clinical Trials 2020
- In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...
Quick links
Infographics
